Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Antibiotics With Antibiotic Impregnated EVDs
NCT05001750Phase 1Recruiting
- Sponsor
- Montefiore Medical Center
- Start
- Jun 2021
- Primary completion
- Aug 2028
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nafcillin and doxycycline in External ventricular drain infection (EVDI) (2 arms), sponsored by Montefiore Medical Center. Primary endpoint: Number of Participants with Cerebrospinal Fluid Positive (CSF+) Ventriculostomy Related Infection (VRI) at 2 weeks. Started Jun 2021; status: recruiting.
02
Drugs
nafcillindoxycycline
03
Conditions
External ventricular drain infection (EVDI)
Beyond the preview
Go deeper on NCT05001750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05001750.